Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)

2016193 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: The Lancet Respiratory Medicine

Volume 5, Issue 1, pp. 51-60

Field-Weighted Citation Impact: 14.61